NEWBURY PHARMACEUTICALS AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.46 SEK | +8.81% |
|
+8.12% | +12.70% |
| Apr. 10 | Newbury Pharmaceuticals AB Reports Earnings Results for the Second Quarter and Six Months Ended February 29, 2024 | CI |
| Feb. 22 | Newbury Pharmaceuticals Secures SEK9 Million Sales Order | MT |
Quotes 5-day view
Delayed Quote Nasdaq Stockholm| 2024-06-14 | 2024-06-18 | 2024-06-19 | 2024-06-20 | |
|---|---|---|---|---|
| Last | 3.22 kr | 3.28 kr | 3.18 kr | 3.46 kr |
| Volume | 36 365 | 11 711 | 13 809 | 52 166 |
| Change | +0.63% | +1.86% | -3.05% | +8.81% |
| Opening | 3.22 | 3.30 | 3.20 | 3.10 |
| High | 3.22 | 3.30 | 3.28 | 3.52 |
| Low | 3.12 | 3.16 | 3.04 | 3.10 |
Performance
| 1 day | +8.81% | ||
| 1 week | +8.12% | ||
| Current month | +13.82% | ||
| 1 month | +14.57% | ||
| 3 months | -9.66% | ||
| 6 months | -8.22% | ||
| Current year | +12.70% | ||
| 1 year | -17.81% |
Volumes
marketsDaily volume
52 166
Estimated daily volume
90 811
Avg. Volume 20 sessions
29 065
Daily volume ratio
3.12
Avg. Volume 20 sessions SEK
100 564.90
Avg. Volume 20 sessions USD
9 555.68
Record volume 1
580 955
Record volume 2
311 430
Record volume 3
294 717
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (SEK)
84 400 968
Capitalization (USD)
8 019 780
Net sales (SEK)
10 266 000
Net sales (USD)
975 475
Number of employees
5
Sales / Employee (SEK)
2 053 200
Sales / Employee (USD)
195 095
Free-Float
46.13 %
Free-Float capitalization (SEK)
31 330 435
Free-Float capitalization (USD)
2 977 018
Average Daily Capital Traded
0.12%
Highs and lows
1 week
3.04
3.52
1 month
2.703.52
Current year
2.706.24
1 year
2.506.24
3 years
2.5013.70
5 years
2.5013.70
10 years
2.5013.70
Indicators
Moving average 5 days
3.29
Moving average 20 days
3.11
Moving average 50 days
3.27
Moving average 100 days
3.73
Price spread / (MMA5)
-5.06%
Price spread / (MMA20)
-10.13%
Price spread / (MMA50)
-5.44%
Price spread / (MMA100)
+7.90%
STIM
RSI 9 days
50.49
RSI 14 days
49.54
Sector Comparison - Retail - Drugs without Grocery
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +8.81% | +8.12% | +12.70% | -17.81% | 8.02M | ||
| +0.08% | -0.68% | -15.68% | -13.62% | 7.81B | ||
| +2.24% | +5.69% | +33.77% | +18.00% | 1.29B | ||
| -1.59% | -0.42% | -14.18% | -19.39% | 340M | ||
| -0.70% | +1.71% | +2.07% | +22.05% | 271M | ||
| +2.04% | +2.56% | +11.11% | 0.00% | 226M | ||
| -3.57% | -10.00% | -25.69% | -38.17% | 71.19M | ||
| -1.66% | +0.04% | +26.08% | +20.98% | 62.64M | ||
| Average | +0.71% | +1.34% | +3.77% | -3.50% | ||
| Weighted average by Cap. | +0.29% | +0.17% | -8.00% | -8.46% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | +12.70% | ||
| 2023 | -56.08% | ||
| 2022 | -44.52% |
- Stock Market
- Equities
- NEWBRY Stock
- Quotes Newbury Pharmaceuticals AB
